Cardiol Therapeutics Registered (A) WKN: A2PA9E ISIN: CA14161Y2006 Forum: Aktien Thema: Hauptdiskussion

Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-label Pilot Study of CardiolRx™ for Recurrent Pericarditis Third IND authorization for CardiolRx™ in cardiovascular disease Study to run in parallel with Company’s multi-national Phase II acute myocarditis trial, expected to commence imminently CardiolRx™ is now eligible for orphan drug status in two indications

https://www.kapitalerhoehungen.de/kommentare/aktien-cardiol-therapeutics-tesla-bayer-ag

Ja echt übel

Was ein Besch.. Markt gerade.. übel.

Dr. Leslie Cooper, Jr., M.D. and Dr. Arvind Bhimaraj, M.D., MPH, Steering Committee members for Cardiol Therapeutics’ clinical trials, will participate in a Virtual Key Opinion Leader (KOL) Webcast hosted by Edward Nash, biotech analyst with Canaccord Genuity, LLC (US) on Thursday, April 21, 2022 at 1:00 pm EDT. The discussion will focus on the potential anti-fibrotic/anti-inflammatory mechanisms of cannabidiol (CBD) and the need for new therapeutic options for the treatment of acute myocarditis and other inflammatory cardiomyopathies that lead to myocardial fibrosis related heart failure. According to the NIH, there are approximately 73K cases of acute myocarditis in the U.S. annually, with no approved therapeutics.

Weg ist er 🥴

Hoffen wir mal, dass die Gewinne nicht gleich wieder abverkauft werden

Schmeckt

es gab insider Käufe und das ist ein Spitzen Nachricht . Da wird in der nächsten Zeit was passieren

https://www.the-financialnews.com/heres-how-investors-can-make-2000-with-this-stock

Cardiol Therapeutics looks ahead to busy 2022 as it advances new treatment options for cardiovascular disease https://www.proactiveinvestors.com/companies/news/977760/cardiol-therapeutics-looks-ahead-to-busy-2022-as-it-advances-new-treatment-options-for-cardiovascular-disease-977760.html Oakville, Ontario – 24. März 2022 – Cardiol Therapeutics Inc. https://www.irw-press.com/de/news/cardiol-therapeutics-berichtet-aus-dem-aktuellen-betrieb-zum-ende-des-geschaeftsjahres-2021_64904.html?isin=CA14161Y2006

Leider alles wieder weg

Schöner Start

ruhe bewahren auch wenns schwer fällt. wird alles gut

Super.nur noch bergab

https://finance.yahoo.com/news/cardiol-therapeutics-receives-clearance-fda-122700335.html